Veterinary Drugs Market to Hit USD 46.12 Billion by 2032; Growing Prevalence of Different Veterinary Diseases to Boost Market Expansion

The global veterinary drugs market size stood at USD 29.00 billion in 2024. The market is estimated to grow from USD 30.54 billion in 2025 to USD 46.12 billion by 2032, portraying a CAGR of 6.1% during the forecast period.

Fortune Business Insights™ presents this information in its report titled, “Veterinary Drugs Market Size, Share & Industry Analysis, By Product (Anti-infectives, Anti-inflammatory, Parasiticides, and Others), By Animal Type (Companion {Feline, Canine, Avian, and Others} and Livestock {Poultry, Porcine, Bovine, and Others}), By Route of Administration (Oral, Parenteral, Topical, and Aerosol), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, and Others), and Regional Forecast, 2025-2032”.

Veterinary drugs are medicines that are used to administer, cure, treat, mitigate, and prevent any form of disease in animals. These are highly used to regulate the animal physiology as well as maintain their health status. Some of its applications include treating diseases and infections in cattle, including foot and mouth diseases, bovine respiratory diseases, avian influenza, and others. These drugs include anti-infective, anti-inflammatory, pain medications, and parasiticides. The growing pet ownerships, demand for animal protein and occurrence of zoonotic diseases drive the market for veterinary drugs.

The COVID-19 pandemic catalyzed market growth, driven by the growing trend of telemedicine in veterinary practice that aided in remote consultations and provided access to veterinary care as well as prescriptions.

Robust Product Offerings Provided by Key Players to Fuel Market Development

In July 2024, a pilot program was launched by Humane Society International/Mexico, which aims to enhance companion animal welfare and improve access to care in rural as well as low-income households in the Aguascalientes.

Growing Incidence of Veterinary Diseases to Augment Market Growth

One of the major factors driving the veterinary drugs market growth is the growing occurrence of different key veterinary diseases, including skin infections, infectious diseases, bovine respiratory disease, mastitis, parasite infections, foot and mouth diseases, and others. With the advancements in animal healthcare and a growing number of diseases, diagnosis for these diseases has been more crucial and accessible, thus leading to the increasing adoption of the product. Additionally, key players in the market are also investing in research and development to bring innovative treatment methods to the market.

Conversely, the availability of illegal veterinary medicines in the industry is hindering market growth.

Top Players Emphasize Acquisitions to Strengthen Their Market Presence

The global market is characterized by higher competition, with different key players focusing on enhancing product offerings, strategic collaborations, and acquisitions. A few of the notable key players in the market are Merck Animal Health, Zoetis Services LLC, and others.

Notable Industry Development:

• February 2025: The U.S. Secretary of Agriculture, Brooke Rollins, declared an investment of USD 1.0 billion in a comprehensive strategy to control Highly Pathogenic Avian Influenza (HPAI), defend the U.S. poultry industry, and lessen egg prices.

List of the Companies Profiled in the Report:

• • Zoetis Services LLC (U.S.)
  • Merck & Co., Inc. (U.S.)
  • Elanco Animal Health Incorporated (U.S.)
  • Boehringer Ingelheim International GmbH (Germany)
  • Ceva (France)
  • Vetoquinol (France)
  • Dechra Pharmaceuticals Limited (U.K.)
  • Virbac Corporation (France)

To get a detailed report summary and research scope of this market, click here:

https://www.fortunebusinessinsights.com/industry-reports/veterinary-drugs-market-100171

Further Report Findings:

• North America held the largest veterinary drugs market share, attributed to the growing pet ownerships, investments in R&D in veterinary medicines, and growing need for animal proteins.
• Market growth in Asia Pacific is driven by the growing disposable income that has resulted in an increasing number of pet parents across the region.
• Market expansion in Europe is due to the growing animal husbandry and demand for animal based proteins that has led to the demand for veterinary drugs.
• In terms of product, the parasiticides segment led the market in 2024 due to its growing demand in controlling parasites such as fleas, worms, and ticks.

Table of Segmentation